Related Experiment Video
Updated: May 23, 2026

Self-Administration of Drugs in Mouse Models of Feeding and Obesity
Published on: June 8, 2021
Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination
P J Pratheesh1, Samir Kumar Praharaj1, Ashish Srivastava1
1Dr. Pratheesh, MBBS, Junior Resident, Department of Psychiatry, Kasturba Medical College, Manipal, Karnataka, India. Dr. Praharaj, MBBS, MD, DPM, Assistant Professor, Department of Psychiatry, Kasturba Medical College, Manipal, Karnataka, India. Dr. Srivastava, MBBS, MD, Assistant Professor, Department of Psychiatry, Institute of Psychiatry and Human Behavior, Bambolim, Goa, India.
Abstract:
Risperidone is associated with hyperprolactinemia and its consequent symptoms such as gynnecomastia, galactorrhea and sexual dysfunction in adults, and less so in adolescents. Rarely, serotonin reuptake inhibitors are also associated with such adverse effects. We report a case of gynecomastia and galactorrhea in an adolescent male while on a combination of risperidone and fluvoxamine, although the serum prolactin was within normal range.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Antidepressant Drugs: MAOIs and Other Agents
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Antipsychotic Drugs: Typical and Atypical Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
